Trump's 'vaccine hesitant’ views run against public opinion, Pew says

As many experts wait anxiously to see how President Donald Trump might act on vaccines, a new survey documents strong support by Americans that the benefits of childhood immunizations outweigh any potential risks.
Pew Research Center reports that 88% of Americans think the benefits of the MMR vaccine outweigh the risks, while one in 10 believe the risks aren’t worth the benefits.
The survey—conducted from May 10 to June 6 last year—found that 82% of Americans are in favor of MMR vaccination requirements for healthy schoolchildren.

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.

China needs tougher enforcement of vaccine regulation: WHO

China must strengthen regulation of its market for vaccines, the World Health Organization (WHO) said on Monday, after a bust of an illegal black market drugs ring this month underscored the country's regulatory weaknesses.
Police have arrested more than 130 suspects over a scandal in which 310 million yuan ($48 million) of illegal vaccines was sold onto the market. The value of the illegal trades could be as much as $90 million.

Afrique: Vaccination infantile - L'Afrique, le continent le moins protégé

La première conférence ministérielle africaine sur la vaccination a ouvert ses travaux, le mercredi 24 février 2016 à Addis Abeba en Ethiopie. Des ministres de la Santé, des Finances, des experts, des décideurs, des bailleurs de fonds et de la société civile réfléchissent aux moyens les plus efficaces afin de parvenir à une couverture vaccinale de tous les enfants du continent.
Etendre la vaccination afin de parvenir à une couverture universelle est le nouveau challenge que les dirigeants africains et leurs partenaires veulent se donner en matière de santé.

Vaccine Exemptions: Time to Tighten the Rules

Hello. I'm Dr Sandra Fryhofer. Welcome to Medicine Matters. The topic: a new policy[1] on nonmedical exemptions to immunization from the American Medical Association (AMA). This segment also includes highlights of a joint report from the AMA Council on Science and Public Health and AMA Council on Ethics and Judicial Affairs, presented to the House of Delegates at its June 2015 meeting. Here's why it matters.

Avant le sida, ces épidémies combattues avec succès par l’homme

Le sida sera-t-il éradiqué d’ici 2030? L’ONU a réaffirmé en juillet cet objectif, alors que le nombre d’infections a enregistré une baisse de 35% depuis 2000. "Nous allons vers une génération sans sida", s'est réjoui le 14 juillet le secrétaire général de l'ONU, Ban Ki-moon, lors d'une visite dans la capitale ethiopienne, Addis-Abeba.

Bavarian Nordic smallpox vaccine scores two late-stage trial wins

Though it's been eradicated, the threat of a smallpox outbreak is taken very seriously by public health officials, an ongoing concern that's helped Bavarian Nordic pay its bills through the years.

With an announcement Wednesday trumpeting two successful late-stage tests, the company has reason to believe it can advance its business with smallpox vaccine Imvamune.


A Very Short History of Vaccines in America

The battle over whether to enforce vaccination is not new. In fact, it’s older than the United States itself.
In early colonial America, the smallpox virus spread quickly among growing populations, killing as many as half of those who caught it. When one of the earliest forms of immunization — called “inoculation” — was introduced in the West, colonizers fought over whether it was safe.

Smallpox vaccine helps Bavarian Nordic net first full-year profit in 5 years

After a four-year drought, Bavarian Nordic has finally had its first full year of profit, and it has its smallpox vaccine to thank.
The company announced Wednesday that it had a full-year net profit of 25.9 Danish kroner ($3.72 million) and that it expects 1.1 billion kroner ($159 million) in revenue for 2015. The Danish biotech said in its annual report that it made most of its fiscal 2014 revenue from sales of Imvamune, its smallpox vaccine, to the U.S. Strategic National Stockpile.

WHO/Europe holds annual laboratory networks meeting in Tunisia

The World Health Organization Regional Office for Europe held the annual meeting of its Measles/Rubella Laboratory Network and Polio Laboratory Network from Sept. 8-12 in Hammamet, Tunisia.
The meeting participants conducted a joint review of the networks’ performance in 2013-2014 and defined future priorities. The Hammamet meeting also allowed WHO/Europe to further strengthen its collaboration with sister networks in the WHO Eastern Mediterranean Region.